Colorcon has announced its investment to build a new starch manufacturing plant close to Amsterdam in The Netherlands. By 2022, this new facility is planned to double the existing manufacturing capacity for Starch 1500®, Pregelatinized Maize Starch, supporting the continued growth of Colorcon’s excipient business.
The site will produce GMP starch products for the pharmaceutical and nutritional markets served by Colorcon in the EMEA region.
“The location has been chosen to bring manufacturing closer to our customer base in Europe. The plant will provide a secure second source of supply with the same quality, consistency and equivalency to the product manufactured in our existing facility in Indianapolis, IN,” Nathan Evans, Operations Project Manager – Netherlands said. “The new facility will enable Colorcon to take advantage of new advances in process control and automation to manufacture a product that has over 40 years of history in use across the pharmaceutical industry.”
“By investing ahead of demand, the facility is also an important step in securing the supply chain for our customers and enhances Colorcon’s Business Continuity Plan as the demand for Starch 1500 continues to grow,” Martti Hedman, CEO, Colorcon.